Masthead

Cover Image - Radiotherapy and Oncology, Volume 165, Issue
Current Issue
Radiotherapy and Oncology

Articles in Press

Issue Highlights

ESTRO 2022
ICHNO-ECHNO 2022

Editor-in-Chief's Pick of the Papers

Open Access Papers for our Readers:
Each issue, the Editor-in-Chief of Radiotherapy and Oncology, picks his favourite paper from the journal. These papers are free to access.
View the collection here.

About

Radiotherapy and Oncology

Cover Image - Radiotherapy and Oncology, Volume 165, Issue

Radiotherapy & Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as physical aspects relevant to oncology, particularly in the field of imaging, dosimetry and radiation therapy planning. More

Society Information

ESTRO

 

 

Founded in 1980, ESTRO, the European SocieTy for Radiotherapy & Oncology, is a non-profit and scientific organisation that fosters the role of Radiation Oncology in order to improve patients’ care in the multimodality treatment of cancer.

With over 6,500 members inside and outside Europe, ESTRO supports all the Radiation Oncology professionals in their daily practice: Radiation Oncologists, Medical Physicists, Radiobiologists and RTTs (Radiation TherapisTs) and the wider oncology community.

ESTRO’s mission is to promote innovation, research, and dissemination of science through its congresses, special meetings, educational courses and publications.

Metrics

Metrics

##
Impact Factor
##
5-Year Impact Factor
##
Eigenfactor Score
1.892
SJR (SCImago Journal Rank)

Companion Journals

Cover Image - Technical Innovations and Patient Support in Radiation Oncology , Volume 20, Issue
Cover Image - Clinical and Translational Radiation Oncology, Volume 32, Issue
Cover Image - Physics and Imaging in Radiation Oncology, Volume 21, Issue undefined

Most Read (Last 30 Days)

Most Cited (Previous 3 Years)

Advertisement